InvestorsHub Logo
Followers 59
Posts 11484
Boards Moderated 0
Alias Born 07/16/2006

Re: pollyvonwog post# 15260

Thursday, 02/04/2016 5:55:38 AM

Thursday, February 04, 2016 5:55:38 AM

Post# of 20689
IMS for 1/22/16

Tecfidera TRX 8,509 -1.2% NRX 2,213 -2.0%

Copaxone TRX 9,154 -4.2% NRX 2,126 -7.7%

Glatopa TRX 710 -3.8% NRX 213 -9.7%

From these numbers I'd say we're stuck in the mud. Roughly speaking, it looks like Teva probably is approaching the 80% mark of converting patients to their 3X dosing schedule. It looks like Teva and Sandoz are just about splitting the Daily users 50-50.

Momenta needs a break.